Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Line item | Sinevo Sakartvelo | Endokrinologiis Erovnul… | Clinic-LJ | National Center of Tube… | B&N Medi |
|---|---|---|---|---|---|
| Total Revenue | 16,124 | 15,944 | 15,596 | 15,540 | — |
| Total COGS | -7,236 | -2,048 | -11,307 | -15,171 | — |
| Gross Profit | 8,887 | 13,896 | 4,289 | 369 | — |
| Gross Margin | 55.1% | 87.2% | 27.5% | 2.4% | — |
| Total Operating Expenses | -4,551 | -11,780 | -2,872 | -3,002 | — |
| EBITDA | 4,336 | 2,116 | 1,417 | -2,633 | — |
| EBITDA Margin | 26.9% | 13.3% | 9.1% | -16.9% | — |
| Total D&A | -844 | -335 | 0 | -529 | — |
| EBIT / Operating Income | 3,492 | 1,781 | 1,417 | -3,162 | — |
| Total Interest Income | 457 | — | — | 164 | — |
| Total Other Income | -36 | 13 | -276 | 251 | — |
| Profit Before Tax | 3,912 | 1,652 | 1,141 | -2,796 | — |
| Total Income Tax | -392 | -162 | -16 | 0 | — |
| Net Profit / (Loss) | 3,897 | 1,490 | 1,125 | -2,796 | — |
| Net Margin | 24.2% | 9.3% | 7.2% | -18.0% | — |
| Total Interest Expense | — | -142 | — | -49 | — |
Not every picked company reports every selected year — FY2024: no filing for B&N Medi. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Sinevo Sakartvelo | Healthcare Services | 26.9% | 87th pct | 268 |
| Endokrinologiis Erovnul… | Healthcare Services | 13.3% | 59th pct | 268 |
| Clinic-LJ | Healthcare Services | 9.1% | 48th pct | 268 |
| National Center of Tube… | Healthcare Services | -16.9% | 10th pct | 268 |
| B&N Medi | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.